Myriad Genetics, Inc. announced the addition of five senior executives to help further strengthen the company's product roadmap and improve commercial execution. Appoints: Marc Leighton recently joined Myriad as Senior Vice President (SVP) for Product Management. Leighton is responsible for leading product strategy across the organization.

He has more than 15 years of experience in healthcare and has held various product leadership roles in both global device and software, most recently as SVP of Product at Florence Healthcare. Glenn Farrell recently joined Myriad as SVP and Chief Marketing Officer (CMO). Farrell is responsible for leading the brand, digital marketing, and communications strategy for the enterprise.

He has more than 25 years of experience leading brand strategy and successful go-to-market programs in healthcare, life sciences and technology. He most recently served as the CMO and founding team member at Sema4 Holdings Corp. Lisa Olson-Coombe recently joined Myriad as VP of Lab Transformation.

Olson-Coombe is responsible for leading Myriad's effort to move and upgrade the primary labs in Salt Lake City and South San Francisco. She has more than 20 years of experience in managing diagnostic lab operations at scale, most recently serving as VP of Laboratory Operations at Exact Sciences Corp. John Oberg will join Myriad as SVP of Business Development effective Jan.

3, 2023. Oberg will be responsible for growing business partnerships and building collaborations with biotech companies, healthcare networks, health systems and academic partners. He has more than 15 years of experience in the areas of healthcare, genomics and precision medicine, most recently serving as Head of Business Development at Invitae Corp.